,,,I wouldnt depend on the market to at this stage to truely value ZEN,,,,,,the last Ptivate Placement might be a better qualifier as to risk/reward pricing,,,,,,,!!,,there might me a later PP that google missed but not likely. So if this what a PP gets, you can be assured the open market would have a higher pricing!

Zenith also announces that it has entered into a definitive stock purchase agreement with an affiliate of Newsoara Biopharma Co., Ltd. (the “Subscriber”) for the private placement of 3,333,334 common shares in tranches at a price of US$1.50 per share for gross proceeds of US$5 million (CAD$6.7 million) on or before August 31, 2020